Erschienen in:
29.11.2021 | Clinical Investigation
Comparison of deep anterior lamellar keratoplasty and corneal cross-linking in patients with advanced keratoconus
verfasst von:
Jinsong Xue, Haiou Wang, Min Wang, Qingyan Zeng, Vishal Jhanji, Andy D. Kim, Michael T. M. Wang, Yingnan Xu, Xiuming Jin, Wei Chen
Erschienen in:
Japanese Journal of Ophthalmology
|
Ausgabe 1/2022
Einloggen, um Zugang zu erhalten
Abstract
Purpose
To compare outcomes of deep anterior lamellar keratoplasty (DALK) and corneal cross-linking (CXL) in patients with advanced keratoconus, with the primary aim of assessing CXL as a potential therapeutic alternative.
Study design
Retrospective, multi-center, comparative study.
Methods
Patients with advanced keratoconus (maximum keratometry reading (K-max) > 58D, best spectacle-corrected visual acuity worse than 0.52logMAR), undergoing either DALK or CXL treatment at four tertiary ophthalmic centers in Wenzhou, Hangzhou, Nanjing and Wuhan were included. Visual acuity, refractive error, corneal topography and complications were evaluated at baseline and at least 2 year postoperatively.
Results
75 eyes of 72 patients were included, of which 37 eyes underwent DALK and 38 eyes, CXL. A larger reduction in Kmax was observed in the DALK group (-18.18 ± 9.44 D versus -1.10 ± 2.70D, p < 0.001). Seven eyes (18%) in the CXL group showed progression of keratoconus. No disease progression was observed in the DALK group. Greater improvements in best spectacle-corrected visual acuity (logMAR) were observed in the DALK group (-0.59 ± 0.25 versus -0.24 ± 0.44, p < 0.001).
Conclusions
Compared to CXL, DALK leads to larger reductions in Kmax and better improvement in visual acuity in advanced keratoconus.